Patents by Inventor Kyle APLEY

Kyle APLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONJUGATES WITH INHIBITORY RECEPTOR LIGANDS TO INDUCE ANERGY IN INSULIN-BINDING B CELLS
    Publication number: 20250222074
    Abstract: The present disclosure provides conjugates, methods of making the same, and uses thereof. The conjugates of the present technology are useful in inducing anergy in insulin-binding B cells.
    Type: Application
    Filed: November 21, 2024
    Publication date: July 10, 2025
    Applicant: UNIVERSITY OF KANSAS
    Inventors: Kyle Apley, Mark Farrell, Cory Berkland
  • Conjugates with inhibitory receptor ligands to induce anergy in insulin-binding B cells
    Patent number: 12150974
    Abstract: The present disclosure provides conjugates, methods of making the same, and uses thereof. The conjugates of the present technology are useful in inducing anergy in insulin-binding B cells.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: November 26, 2024
    Assignee: UNIVERSITY OF KANSAS
    Inventors: Kyle Apley, Mark Farrell, Cory Berkland
  • CONJUGATES WITH INHIBITORY RECEPTOR LIGANDS TO INDUCE ANERGY IN INSULIN-BINDING B CELLS
    Publication number: 20240269239
    Abstract: The present disclosure provides conjugates, methods of making the same, and uses thereof. The conjugates of the present technology are useful in inducing anergy in insulin-binding B cells.
    Type: Application
    Filed: January 27, 2022
    Publication date: August 15, 2024
    Inventors: Kyle APLEY, Mark FARRELL, Cory BERKLAND